URMC / Medicine / Allergy, Immunology, and Rheumatology / In the News In the News 20212020201920182017 Dr. Christopher Palma Leads Study of COVID Treatment at URMCMonday, March 29, 2021Under the supervision of Christopher Palma, MD, ScM, a clinical trial looking at ruxolitinib as a possible medication to treat COVID-19 patients, was studied at URMC. The medication is currently pending FDA approval. Learn more in the press release from the manufacturer of the drug, Incyte.